Health and Me

Tanya Dutt

A Pill In Your Cabinet That 'Millions' Take Could Help Fight The Deadliest Breast Cancer

A medication prescribed for decades to lower blood pressure may hold a surprising new use: slowing the spread of one of the most aggressive and deadly forms of <span><a href="https://www.healthandme.com/health/breast-cancer">breast cancer</a></span>. Scientists at Monash University in Melbourne have discovered that <span>beta blockers</span>, medicines already used daily by millions, may shield women from triple-negative breast cancer (TNBC), a type that has few effective treatments and bleak survival rates.

The results, which appeared in Science Signaling, indicate that this group of heart drugs may open a whole new avenue in battling TNBC, providing promise to a disease that disproportionately harms younger women and is notoriously resistant to treatment.

Breast cancer is not one but a group of subtypes, each with a variable response to treatment. TNBC is characterized by what it does not have: it is receptor-negative for estrogen and progesterone receptors and non-secretor of excess HER2 protein. Lacking those targets, therapies that are effective for other breast cancers—hormonal therapies or drugs targeting HER2—are not effective.

TNBC, as defined by the American Cancer Society, grows and develops more rapidly than others, giving patients fewer treatment options and poorer prognoses. While about 90 percent of women diagnosed with other breast cancers survive at least five years, that number drops to around 77 percent for TNBC. For women with advanced-stage disease, the survival rate can fall as low as 12 percent.

The Monash University team wanted to understand why beta blockers, medications that work by blocking stress hormones like adrenaline, were associated with better outcomes in some TNBC patients. Previous studies had hinted at a link, but the underlying mechanism remained a mystery.

Their research uncovered a crucial detail: stress hormones can activate a receptor called the beta-2 adrenoceptor, which then sets off a cascade of signaling molecules—including cAMP and calcium—that accelerate cancer growth. This process is powered by a gene called HOXC12, which effectively “fuels” the tumor’s progression.

Here’s where beta blockers come in. By targeting the beta-2 receptor, they can switch off HOXC12, halting the process at its source. In short, a drug that slows a racing heart may also slow a racing tumor.

<h2>How Beta-Blockers Help Fight Cancer Growth?</h2>

The potential impact of this discovery lies not just in its scientific novelty but in its accessibility. Beta blockers are among the most commonly prescribed drugs in the world. One in ten Americans already takes them for conditions ranging from high blood pressure to heart rhythm disorders.

“Ultimately, this exciting discovery could pave the way to improving survival outcomes in people with TNBC when HOXC12 is found to be present,” said Terrance Lam, PhD candidate and first author of the study. “We believe further studies are urgently needed to determine if HOXC12 can be used to identify patients who will benefit from beta blocker therapy at the time of diagnosis and stop tumor spread.”

Professor Michelle Halls, senior author of the study, called the findings “exciting,” adding that the research not only confirmed the potential link between beta blockers and tumor progression but also explained why the drugs could be effective in slowing cancer spread.

One of the most promising aspects of the study is its potential to identify which patients are most likely to benefit. Researchers noted that high levels of HOXC12 expression were strongly associated with poorer survival outcomes. This means HOXC12 could serve as a diagnostic marker—helping doctors determine, at the time of diagnosis, whether beta blockers might be added to a patient’s treatment plan.

If validated in larger trials, this approach could make TNBC treatment more personalized and cost-effective. Instead of waiting for new experimental drugs to be developed, physicians might be able to repurpose a safe, widely available medication to immediately improve outcomes.

TNBC accounts for about 15 percent of all breast cancers in both the US and the UK. While most breast cancer patients now survive at least five years thanks to improved therapies, TNBC remains stubbornly resistant to progress.

Because TNBC does not respond to hormone or HER2-targeted therapies, treatment usually relies on chemotherapy, radiation, and surgery. Immunotherapy has shown promise for some patients, but it is expensive, not universally available, and not always effective.

For this reason, the possibility of adding beta blockers—drugs that cost pennies a pill and are already well understood—could represent a major shift in the global fight against breast cancer.

<h2>How Important Is Mental Health For Cancer Behaviour?</h2>

The study also highlights the role of stress in cancer biology. Stress hormones such as cortisol and adrenaline don’t just affect mood and blood pressure; they can also influence the way cancer cells behave. By showing that stress-related pathways drive tumor growth, the research makes a strong case for viewing cancer not only as a disease of genetics but also as one shaped by the body’s physiological responses.

This finding echoes a broader movement in oncology, integrating psychological care and stress management as part of cancer treatment. While beta blockers may provide a pharmacological way to interrupt stress signaling, lifestyle interventions—such as mindfulness, counseling, and stress reduction—could also complement medical treatment.

<h2>What This Means For Cancer Patients Right Now?</h2>

It’s important to stress that while the research is promising, it’s still in its early stages. The Monash team has identified a mechanism and a potential pathway, but clinical trials are needed before beta blockers can be officially recommended as part of TNBC treatment.

For now, experts urge patients not to self-prescribe or change medications without consulting their doctors. While beta blockers are generally safe, they can cause side effects and interact with other medications.

<h2>Signs Of Breast Cancer That Aren't A Lump</h2>

Still, the research represents a rare piece of good news in the fight against TNBC—a cancer subtype that has long frustrated patients and doctors alike. Recognizing breast cancer beyond lumps. Most people associate breast cancer with the discovery of a lump. But doctors emphasize that other visual and physical signs can also be key to early detection. These include:

<ul><li>Nipple changes or bloody discharge</li><li>Breast dimpling or skin thickening</li><li>A sore on the breast that does not heal</li><li>Swollen lymph nodes in the armpit</li><li>Unexplained breast pain</li></ul>

Experts recommend regular self-checks, paying attention not only to touch but also to visual changes in the mirror. Early detection remains the most powerful tool in improving survival outcomes across all breast cancer types, including TNBC.

Beta blockers, once thought of solely as heart medications, could become an unexpected ally in the battle against triple-negative breast cancer. By targeting stress hormone pathways and shutting down the <span>HOXC12 gene</span>, they may offer a low-cost, widely accessible way to slow tumor progression.

Health Conditions A-Z

health

breast cancer

triple negative breast cancer

beta blockers

breast cancer treatment

stress hormones and cancer

hoxc12 gene

cancer survival rates

blood pressure drug cancer research

First Human West Nile Case Reported In Maryland While Kansas Battles Six Infections

Serena Williams Opens Up About Losing 31 lbs With GLP-1 Medication; Is This Breaking Stigma Or Joining The Trend?

Health News

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

Superfoods That Support Your Gut Health

Immune-Boosting Foods To Have During Rainy Season

Potato Based Dishes You For Week-Long Meal Prep

Weight Loss Dishes With Fruits You Should Try

Stress Vs. Anxiety: Difference Explained In 60 seconds

Can You Get Heatstroke In Monsoon?

You’re Not Lazy! Women Do Need More Sleep Than Men

How To Ditch Daytime Sleepiness In Office?

Common Mistakes People Make While Eating Flaxseeds

Toddlers In India Are Missing Development Milestones: Study

Yoga Poses You Should Do For Back Pain

Healthy Brunch Ideas For A Lazy Weekend Meal

Balancing Exercises You Should Do For Stability

How Much Can Food Affect Menstruation?

What Should Fitness Look Like For A 13-18 Year Old

Food For Diabetes: What Should A Diabetic Diet Contain

You Don’t Always Need Weights For Strength Training

Feel Sleepy After Lunches - Light And Healthy Office Lunches

Positive Thinking Practice – How Does It Help You?

A medication prescribed for decades to lower blood pressure may hold a surprising new use: slowing the spread of one of the most aggressive and deadly forms of breast cancer. Scientists at Monash University in Melbourne have discovered that beta blockers, medicines already used daily by millions, may shield women from triple-negative breast cancer (TNBC), a type that has few effective treatments and bleak survival rates.The results, which appeared in Science Signaling, indicate that this group of heart drugs may open a whole new avenue in battling TNBC, providing promise to a disease that disproportionately harms younger women and is notoriously resistant to treatment.Breast cancer is not one but a group of subtypes, each with a variable response to treatment. TNBC is characterized by what it does not have: it is receptor-negative for estrogen and progesterone receptors and non-secretor of excess HER2 protein. Lacking those targets, therapies that are effective for other breast cancers—hormonal therapies or drugs targeting HER2—are not effective.TNBC, as defined by the American Cancer Society, grows and develops more rapidly than others, giving patients fewer treatment options and poorer prognoses. While about 90 percent of women diagnosed with other breast cancers survive at least five years, that number drops to around 77 percent for TNBC. For women with advanced-stage disease, the survival rate can fall as low as 12 percent.Can Stress Fuel Cancer Growth?The Monash University team wanted to understand why beta blockers, medications that work by blocking stress hormones like adrenaline, were associated with better outcomes in some TNBC patients. Previous studies had hinted at a link, but the underlying mechanism remained a mystery.Their research uncovered a crucial detail: stress hormones can activate a receptor called the beta-2 adrenoceptor, which then sets off a cascade of signaling molecules—including cAMP and calcium—that accelerate cancer growth. This process is powered by a gene called HOXC12, which effectively “fuels” the tumor’s progression.Here’s where beta blockers come in. By targeting the beta-2 receptor, they can switch off HOXC12, halting the process at its source. In short, a drug that slows a racing heart may also slow a racing tumor.How Beta-Blockers Help Fight Cancer Growth?The potential impact of this discovery lies not just in its scientific novelty but in its accessibility. Beta blockers are among the most commonly prescribed drugs in the world. One in ten Americans already takes them for conditions ranging from high blood pressure to heart rhythm disorders.“Ultimately, this exciting discovery could pave the way to improving survival outcomes in people with TNBC when HOXC12 is found to be present,” said Terrance Lam, PhD candidate and first author of the study. “We believe further studies are urgently needed to determine if HOXC12 can be used to identify patients who will benefit from beta blocker therapy at the time of diagnosis and stop tumor spread.”Professor Michelle Halls, senior author of the study, called the findings “exciting,” adding that the research not only confirmed the potential link between beta blockers and tumor progression but also explained why the drugs could be effective in slowing cancer spread.A New Cancer Diagnostic Marker?One of the most promising aspects of the study is its potential to identify which patients are most likely to benefit. Researchers noted that high levels of HOXC12 expression were strongly associated with poorer survival outcomes. This means HOXC12 could serve as a diagnostic marker—helping doctors determine, at the time of diagnosis, whether beta blockers might be added to a patient’s treatment plan.If validated in larger trials, this approach could make TNBC treatment more personalized and cost-effective. Instead of waiting for new experimental drugs to be developed, physicians might be able to repurpose a safe, widely available medication to immediately improve outcomes.TNBC accounts for about 15 percent of all breast cancers in both the US and the UK. While most breast cancer patients now survive at least five years thanks to improved therapies, TNBC remains stubbornly resistant to progress.Because TNBC does not respond to hormone or HER2-targeted therapies, treatment usually relies on chemotherapy, radiation, and surgery. Immunotherapy has shown promise for some patients, but it is expensive, not universally available, and not always effective.For this reason, the possibility of adding beta blockers—drugs that cost pennies a pill and are already well understood—could represent a major shift in the global fight against breast cancer.How Important Is Mental Health For Cancer Behaviour?The study also highlights the role of stress in cancer biology. Stress hormones such as cortisol and adrenaline don’t just affect mood and blood pressure; they can also influence the way cancer cells behave. By showing that stress-related pathways drive tumor growth, the research makes a strong case for viewing cancer not only as a disease of genetics but also as one shaped by the body’s physiological responses.This finding echoes a broader movement in oncology, integrating psychological care and stress management as part of cancer treatment. While beta blockers may provide a pharmacological way to interrupt stress signaling, lifestyle interventions—such as mindfulness, counseling, and stress reduction—could also complement medical treatment.What This Means For Cancer Patients Right Now?It’s important to stress that while the research is promising, it’s still in its early stages. The Monash team has identified a mechanism and a potential pathway, but clinical trials are needed before beta blockers can be officially recommended as part of TNBC treatment.For now, experts urge patients not to self-prescribe or change medications without consulting their doctors. While beta blockers are generally safe, they can cause side effects and interact with other medications.Signs Of Breast Cancer That Aren't A LumpStill, the research represents a rare piece of good news in the fight against TNBC—a cancer subtype that has long frustrated patients and doctors alike. Recognizing breast cancer beyond lumps. Most people associate breast cancer with the discovery of a lump. But doctors emphasize that other visual and physical signs can also be key to early detection. These include:Nipple changes or bloody dischargeBreast dimpling or skin thickeningA sore on the breast that does not healSwollen lymph nodes in the armpitUnexplained breast painExperts recommend regular self-checks, paying attention not only to touch but also to visual changes in the mirror. Early detection remains the most powerful tool in improving survival outcomes across all breast cancer types, including TNBC.Beta blockers, once thought of solely as heart medications, could become an unexpected ally in the battle against triple-negative breast cancer. By targeting stress hormone pathways and shutting down the HOXC12 gene, they may offer a low-cost, widely accessible way to slow tumor progression.

a pill in your cabinet that 'millions' take could help fight the deadliest breast cancer

Health & Wellness

Top 5 US States With Highest Risk Of COVID-19: CDC Uses This Method To Map COVID Risk

top 5 us states with highest risk of covid-19 - cdc uses this method to map covid risk

Bubonic Plague California Resident: Here's All That You Need To Know About The Disease

what is bubonic plague? california case sparks health alert check symptoms and everything you need to know

What History Teaches Us About Plague? Are There More Than One Type?

california resident lake tahoe tests positive for plague what does bubonic plague the black death from rodents teach us are there more than one type of plague

RFK Jr. Slams Pediatricians' Community For Contrasting Vaccine Recommendations

rfk jr. slams pediatricians' community for contrasting vaccine recommendations

Maryland has reported its first human case of <span>West Nile virus</span> (WNV) of 2025, according to the state’s Department of Health. The patient was an adult resident of central Maryland, and officials said Friday that the patient was recovering from the disease. This news highlights the ongoing caution needed as mosquito season picks up across the United States.

West Nile virus is transmitted primarily through bites from infected mosquitoes that have previously fed on birds carrying the virus. While rare, the disease can occasionally spread through other avenues, but mosquito transmission remains the most common pathway.

The majority of individuals who contract WNV have no symptoms, but in certain instances, particularly in patients with underlying disease, the virus can result in serious disease. The Centers for Disease Control and Prevention (CDC) states that common symptoms develop 2–6 days following an infectious mosquito bite and might include high fever, headache, stiff neck, confusion, tremor, convulsions, loss of vision, weakness of muscles, numbness, or paralysis.

Health authorities note that there is no antiviral treatment available for West Nile virus. The vast majority of patients recover completely, although neuroinvasive infections—where the virus invades the central nervous system—are intensive to treat and tend to have more extended recovery times.

Kansas public health officials are tracking six WNV cases this year thus far. Five of these cases have been designated as neuroinvasive, illustrating the severity of the virus. There were three cases reported in north-central Kansas, and three in south-central Kansas. Non-neuroinvasive cases usually exhibit milder, flu-like illnesses, while neuroinvasive cases can include inflammation of the brain or the surrounding tissues, confusion, paralysis, and loss of vision, said Jill Bronaugh, a KDHE spokesperson.

Though numbers fall short of last year's figures—64 cases and four fatalities—officials caution that mosquito activity will peak in late summer, raising the potential for more cases. To monitor developments, KDHE hosts a weekly-updated West Nile virus dashboard for the surveillance season, which runs July to September. 

<h2>Is This A Seasonal Surge Or A Cause Of Concern?</h2>

The CDC reports that WNV activity in the United States normally begins in mid-August and lasts until early September. Around 2,000 individuals are diagnosed with the virus every year, although cases of mild or asymptomatic infections tend to be under-reported. The health authorities advise residents to use preventive strategies, such as using insect repellents, long sleeves, and pants while outdoors, and removing standing water near homes, which is a mosquito breeding site.

"Prevention is the key," states Dr. Emily Johnson, an infectious disease expert. "Because there's no treatment for West Nile, avoiding exposure to mosquitoes through bites is still the best way to stay safe and your family." 

<h2>Can Mosquito Saliva Improve West Nile Virus Treatment?</h2>

In addition to prevention on a case-by-case basis, scientists are looking at new approaches to fighting mosquito-borne illnesses, such as WNV. Anita Saraf, director of the University of Kansas's Mass Spectrometry &amp; Analytical Proteomics Laboratory, is researching mosquito saliva to determine how viruses are transferred and to discover possible therapy targets.

Saliva collection from mosquitoes is technically difficult because they only produce minuscule amounts. USDA Agricultural Research Service collaborators stimulate the mosquitoes to produce saliva, which is analyzed using sophisticated mass spectrometry procedures by researchers. Saraf's research is being done on the proteome—the entire complement of proteins—in mosquito saliva and how it gives clues about how viruses such as West Nile, dengue, yellow fever, and Japanese encephalitis go about controlling the mosquito host and then impact humans.

Her work utilizes shotgun proteomics in tandem with nanoscale liquid chromatography and tandem mass spectrometry (nLC-MS), methods sensitive enough to examine nano-gram levels of protein. "Without the sensitivity, we would require much larger protein samples," Saraf says. "Our strategy permits us to explore these viruses at the molecular level, which might guide future vaccine or therapeutic design."

<h2>Preventive Measures For People To Follow</h2>

Health officials continue to emphasize simple prevention measures as the best defense against WNV. These are:

<ul><li>Using EPA-approved insect repellents</li><li>Wearing long-sleeved shirts and pants outside</li><li>Adding screens on windows and doors to prevent mosquitoes from entering</li><li>Eliminating standing water within homes, such as flowerpots, gutters, and bird baths</li></ul>

By doing these, residents will be able to drastically lower their chances of infection, particularly when it comes to the active mosquito season.

While Kansas and Maryland are tracking WNV cases at present, the threat is spread throughout the U.S. and the world. The CDC reports that West Nile virus is a continued public health issue every summer, especially in areas with high mosquito populations. Rare neuroinvasive cases show the virus's ability to cause significant damage to the nervous system, highlighting awareness and prevention.

The research undertaken currently at the University of Kansas demonstrates the innovative work towards understanding mosquito-borne viruses at a molecular level.

west nile virus outbreak

west nile virus

kansas wnv cases

maryland west nile

mosquito borne diseases

neuroinvasive west nile

cdc mosquito precautions

wnv outbreak 2025

Maryland has reported its first human case of West Nile virus (WNV) of 2025, according to the state’s Department of Health. The patient was an adult resident of central Maryland, and officials said Friday that the patient was recovering from the disease. This news highlights the ongoing caution needed as mosquito season picks up across the United States.West Nile virus is transmitted primarily through bites from infected mosquitoes that have previously fed on birds carrying the virus. While rare, the disease can occasionally spread through other avenues, but mosquito transmission remains the most common pathway.The majority of individuals who contract WNV have no symptoms, but in certain instances, particularly in patients with underlying disease, the virus can result in serious disease. The Centers for Disease Control and Prevention (CDC) states that common symptoms develop 2–6 days following an infectious mosquito bite and might include high fever, headache, stiff neck, confusion, tremor, convulsions, loss of vision, weakness of muscles, numbness, or paralysis.Health authorities note that there is no antiviral treatment available for West Nile virus. The vast majority of patients recover completely, although neuroinvasive infections—where the virus invades the central nervous system—are intensive to treat and tend to have more extended recovery times.Kansas public health officials are tracking six WNV cases this year thus far. Five of these cases have been designated as neuroinvasive, illustrating the severity of the virus. There were three cases reported in north-central Kansas, and three in south-central Kansas. Non-neuroinvasive cases usually exhibit milder, flu-like illnesses, while neuroinvasive cases can include inflammation of the brain or the surrounding tissues, confusion, paralysis, and loss of vision, said Jill Bronaugh, a KDHE spokesperson.Though numbers fall short of last year's figures—64 cases and four fatalities—officials caution that mosquito activity will peak in late summer, raising the potential for more cases. To monitor developments, KDHE hosts a weekly-updated West Nile virus dashboard for the surveillance season, which runs July to September. Is This A Seasonal Surge Or A Cause Of Concern?The CDC reports that WNV activity in the United States normally begins in mid-August and lasts until early September. Around 2,000 individuals are diagnosed with the virus every year, although cases of mild or asymptomatic infections tend to be under-reported. The health authorities advise residents to use preventive strategies, such as using insect repellents, long sleeves, and pants while outdoors, and removing standing water near homes, which is a mosquito breeding site."Prevention is the key," states Dr. Emily Johnson, an infectious disease expert. "Because there's no treatment for West Nile, avoiding exposure to mosquitoes through bites is still the best way to stay safe and your family." Can Mosquito Saliva Improve West Nile Virus Treatment?In addition to prevention on a case-by-case basis, scientists are looking at new approaches to fighting mosquito-borne illnesses, such as WNV. Anita Saraf, director of the University of Kansas's Mass Spectrometry & Analytical Proteomics Laboratory, is researching mosquito saliva to determine how viruses are transferred and to discover possible therapy targets.Saliva collection from mosquitoes is technically difficult because they only produce minuscule amounts. USDA Agricultural Research Service collaborators stimulate the mosquitoes to produce saliva, which is analyzed using sophisticated mass spectrometry procedures by researchers. Saraf's research is being done on the proteome—the entire complement of proteins—in mosquito saliva and how it gives clues about how viruses such as West Nile, dengue, yellow fever, and Japanese encephalitis go about controlling the mosquito host and then impact humans.Her work utilizes shotgun proteomics in tandem with nanoscale liquid chromatography and tandem mass spectrometry (nLC-MS), methods sensitive enough to examine nano-gram levels of protein. "Without the sensitivity, we would require much larger protein samples," Saraf says. "Our strategy permits us to explore these viruses at the molecular level, which might guide future vaccine or therapeutic design."Preventive Measures For People To FollowHealth officials continue to emphasize simple prevention measures as the best defense against WNV. These are:Using EPA-approved insect repellentsWearing long-sleeved shirts and pants outsideAdding screens on windows and doors to prevent mosquitoes from enteringEliminating standing water within homes, such as flowerpots, gutters, and bird bathsBy doing these, residents will be able to drastically lower their chances of infection, particularly when it comes to the active mosquito season.While Kansas and Maryland are tracking WNV cases at present, the threat is spread throughout the U.S. and the world. The CDC reports that West Nile virus is a continued public health issue every summer, especially in areas with high mosquito populations. Rare neuroinvasive cases show the virus's ability to cause significant damage to the nervous system, highlighting awareness and prevention.The research undertaken currently at the University of Kansas demonstrates the innovative work towards understanding mosquito-borne viruses at a molecular level.

first human west nile case reported in maryland while kansas battles six infections

Ishita Roy

Young Kids Should Get Covid-19 Vaccine: US Pediatric Group Breaks Away From CDC Guidelines

Canada Reports First Tick-Borne Rocky Mountain Spotted Fever, How To Spot The First Symptoms

canada reports first tick-borne rocky mountain spotted fever, how to spot the first symptoms

August 19 marked a sharp split in U.S. vaccine policy after the American Academy of Pediatrics (AAP) released updated immunization guidelines that call for <span>COVID-19</span> vaccination in young children. The move breaks from recent federal guidance shaped by Health and Human Services Secretary Robert F. Kennedy Jr.

The AAP, which represents more than 65,000 board-certified pediatricians, has long been a central authority on children’s health. In June, the organization had already signaled its concern, saying the federal process for creating vaccine schedules was “no longer credible” after Kennedy dismissed the 17-member Advisory Committee on Immunization Practices. That panel traditionally guides the CDC’s vaccine recommendations.

Kennedy replaced the group with appointees that many in the medical community consider unqualified, several with ties to anti-vaccine organizations. The May announcement that COVID-19 vaccines would no longer be on the CDC’s recommended list for healthy children and pregnant women further deepened tensions.

“The AAP will continue to provide recommendations that are rooted in science and in the best interest of children and families,” AAP President Dr. Susan J. Kressly said in a statement.

<strong>Also Read: <a href="https://www.healthandme.com/health-news/rfk-jr-announces-cdc-no-longer-recommends-covid-vaccine-for-kids-and-pregnant-women-what-do-experts-think-article-151745014" data-type="tilCustomLink">CDC No Longer Recommends COVID Vaccine For Kids And Pregnant Women - What Do Experts Think?</a></strong>

<h3>What the AAP Recommends for Kids</h3>

The updated AAP schedule covers vaccines from birth through age 18, including influenza, RSV, and COVID-19. The pediatric group recommends:

<strong>Ages 6 months to 23 months: </strong>All children should receive the updated COVID-19 vaccine to lower the risk of severe illness.

<strong>Ages 2 to 18:</strong> Children and adolescents without other high-risk conditions should be offered the vaccine if not already immunized.

<strong>High-risk children and adults: </strong>Those with conditions like weakened immune systems should receive the vaccine regardless of age.

The organization stressed that its guidance is based on peer-reviewed evidence, countering federal messaging that leaves vaccination decisions to parental consultation with physicians.

The CDC has not completely eliminated COVID-19 vaccination from its schedule but shifted language in August to a softer stance. Instead of recommending annual doses for children, the agency now advises parents to “consult with their child’s physician” to decide.

Kennedy has said publicly that the vaccine should be reserved for people over 65 or those at high risk. The CDC website still lists recommendations for everyone over six months, but with a notice that the information is being updated to reflect new schedules.

Experts have warned this change may create barriers to access, since insurance coverage often mirrors CDC recommendations. Families who want their children vaccinated but do not fall under the new federal priority categories could be forced to pay out of pocket.

<strong>Read More: <a href="https://www.healthandme.com/health-news/fda-approves-new-covid-vaccine-for-kids-with-selective-eligibility-article-152262209" data-type="tilCustomLink">FDA Approves New Covid Vaccine For Kids With Selective Eligibility</a></strong>

<h2>The Growing Clash Between AAP and HHS</h2>

The disagreement has sparked sharp exchanges between pediatric leaders and the federal government. HHS Communications Director Andrew Nixon accused the AAP of advancing commercial interests, citing pharmaceutical funding ties.

“By bypassing the CDC’s advisory process and issuing its own recommendations, the AAP is putting politics above children’s health,” Nixon said in a statement.

Kennedy echoed those concerns on social media, calling the pediatric guidance “corporate-friendly” and suggesting it primarily benefits vaccine manufacturers. He also warned that diverging from federal recommendations could leave doctors legally vulnerable, since liability protections under the Vaccine Injury Act apply only to CDC-approved schedules.

AAP President Dr. Kressly rejected those claims. “This attack on the integrity of pediatricians is unfortunate, but it does not change the facts. Our immunization recommendations are rooted in decades of peer-reviewed science,” she said.

The newly appointed federal Advisory Committee on Immunization Practices has not yet voted on COVID-19 guidance and is expected to meet again in early fall. Meanwhile, the FDA is weighing whether to revoke authorization of the Pfizer COVID-19 vaccine for healthy children.

The split leaves parents facing a confusing landscape. While federal authorities have scaled back recommendations, pediatricians say the science still supports protecting children with the COVID-19 shot. As the AAP put it, the mission is clear: to keep kids, families, and communities healthy, regardless of shifting political winds.

COVID-19

AAP recommends covid 19 vaccine for kids

health news

health news USA

covid 19

covid 19 vaccines

covid 19 vaccines for kids

CDC says no covid 19 vaccine for kids

August 19 marked a sharp split in U.S. vaccine policy after the American Academy of Pediatrics (AAP) released updated immunization guidelines that call for COVID-19 vaccination in young children. The move breaks from recent federal guidance shaped by Health and Human Services Secretary Robert F. Kennedy Jr.Why the AAP is Standing ApartThe AAP, which represents more than 65,000 board-certified pediatricians, has long been a central authority on children’s health. In June, the organization had already signaled its concern, saying the federal process for creating vaccine schedules was “no longer credible” after Kennedy dismissed the 17-member Advisory Committee on Immunization Practices. That panel traditionally guides the CDC’s vaccine recommendations.Kennedy replaced the group with appointees that many in the medical community consider unqualified, several with ties to anti-vaccine organizations. The May announcement that COVID-19 vaccines would no longer be on the CDC’s recommended list for healthy children and pregnant women further deepened tensions.“The AAP will continue to provide recommendations that are rooted in science and in the best interest of children and families,” AAP President Dr. Susan J. Kressly said in a statement.Also Read: CDC No Longer Recommends COVID Vaccine For Kids And Pregnant Women - What Do Experts Think?What the AAP Recommends for KidsThe updated AAP schedule covers vaccines from birth through age 18, including influenza, RSV, and COVID-19. The pediatric group recommends:Ages 6 months to 23 months: All children should receive the updated COVID-19 vaccine to lower the risk of severe illness.Ages 2 to 18: Children and adolescents without other high-risk conditions should be offered the vaccine if not already immunized.High-risk children and adults: Those with conditions like weakened immune systems should receive the vaccine regardless of age.The organization stressed that its guidance is based on peer-reviewed evidence, countering federal messaging that leaves vaccination decisions to parental consultation with physicians.Federal Guidance Under KennedyThe CDC has not completely eliminated COVID-19 vaccination from its schedule but shifted language in August to a softer stance. Instead of recommending annual doses for children, the agency now advises parents to “consult with their child’s physician” to decide.Kennedy has said publicly that the vaccine should be reserved for people over 65 or those at high risk. The CDC website still lists recommendations for everyone over six months, but with a notice that the information is being updated to reflect new schedules.Experts have warned this change may create barriers to access, since insurance coverage often mirrors CDC recommendations. Families who want their children vaccinated but do not fall under the new federal priority categories could be forced to pay out of pocket.Read More: FDA Approves New Covid Vaccine For Kids With Selective EligibilityThe Growing Clash Between AAP and HHSThe disagreement has sparked sharp exchanges between pediatric leaders and the federal government. HHS Communications Director Andrew Nixon accused the AAP of advancing commercial interests, citing pharmaceutical funding ties.“By bypassing the CDC’s advisory process and issuing its own recommendations, the AAP is putting politics above children’s health,” Nixon said in a statement.Kennedy echoed those concerns on social media, calling the pediatric guidance “corporate-friendly” and suggesting it primarily benefits vaccine manufacturers. He also warned that diverging from federal recommendations could leave doctors legally vulnerable, since liability protections under the Vaccine Injury Act apply only to CDC-approved schedules.AAP President Dr. Kressly rejected those claims. “This attack on the integrity of pediatricians is unfortunate, but it does not change the facts. Our immunization recommendations are rooted in decades of peer-reviewed science,” she said.What Comes NextThe newly appointed federal Advisory Committee on Immunization Practices has not yet voted on COVID-19 guidance and is expected to meet again in early fall. Meanwhile, the FDA is weighing whether to revoke authorization of the Pfizer COVID-19 vaccine for healthy children.The split leaves parents facing a confusing landscape. While federal authorities have scaled back recommendations, pediatricians say the science still supports protecting children with the COVID-19 shot. As the AAP put it, the mission is clear: to keep kids, families, and communities healthy, regardless of shifting political winds.

young kids should get covid-19 vaccine: us pediatric group breaks away from cdc guidelines

Contact Lens Health Week 2025: Why Is It Important For Us To Observe A Week For Eye Health?

Wearing Contact Lenses This Monsoon? Here Is What Eye Doctors Want You to Know

wearing contact lenses this monsoon? here is what eye doctors want you to know

Deepfake Doctor Videos Are Pushing False Medical Advice, How Can You Identify Medical Misinformation

deepfake doctor videos are pushing false medical advice, how can you identify medical misinformation

Is Your Child Just Shy or Socially Anxious? Experts Weigh In

is your child just shy or socially anxious? experts weigh in

<span>Contact Lens Health Week</span>, observed annually in the third week of August, comes to a close today. This year, it ran from August 18 to 22, serving as an important reminder of how crucial <span>eye health</span> is in our daily lives. While it may seem like a niche health observance, the initiative highlights an issue that affects millions worldwide: the proper care and safe use of contact lenses.

<h2>Why Eye Health Cannot Be Overlooked</h2>

Vision is one of the most vital senses, yet it is often taken for granted. With modern technology, access to corrective options such as glasses, contact lenses, surgeries, and even transplants has made many believe that eyesight will always be easily restorable. But experts emphasize that carelessness with something as simple as contact lenses can lead to lasting damage. Contact lenses sit directly on the eye, and poor hygiene or overuse can compromise vision. This is exactly why <span>Contact Lens Health</span> Week remains significant.

<h2>A Brief History of Vision Correction</h2>

The journey of improving human sight stretches back centuries. Records suggest that spectacles first appeared in the late 1200s to early 1300s, with Salvino D’Armate often credited as their inventor. Initially, these crude lenses were luxury items reserved for the wealthy. By the time of the industrial revolution, glasses became widely available and affordable, changing lives across classes.

In the early 1800s, scientist Thomas Young built the first prototype of a <span>contact lens</span>, using wax and water-filled lenses. Over the following century and a half, various improvements led to a more practical design. By the 1940s, significant strides had been made in creating lenses suitable for everyday wear. However, it wasn’t until the introduction of soft lenses in the 1970s that contact lenses truly became mainstream.

<h2>The Rise of Contact Lenses, and the Risks</h2>

Today, millions of people choose between glasses and contact lenses. Contact lenses offer freedom, convenience, and in many cases, improved aesthetics. Yet, their popularity has also led to widespread misuse. Many users overlook the two key rules: sticking to the replacement schedule and respecting the wear schedule. Even the most advanced lenses should not be worn beyond 30 consecutive days and nights. Ignoring this can reduce oxygen flow to the eyes, cause infections, and in severe cases, lead to vision loss.

<h2>Why Contact Lens Health Week Matters</h2>

The week serves as a call to action for everyone who relies on contact lenses. It emphasizes the need for proper cleaning, regular replacement, and awareness of risks linked to negligence. Simple practices, like washing hands before touching lenses, never reusing solution, and removing lenses before sleeping, can prevent long-term harm.

<h2>Milestones in Contact Lens Development</h2>

<strong>1508: </strong>Leonardo da Vinci illustrates the first concept of contact lenses.

<strong>1939: </strong>Plastic technology enables the creation of the first plastic contact lenses.

<strong>1971: </strong>Soft contact lenses gain public approval for comfort.

<strong>1987: </strong>Disposable soft contact lenses are introduced, making them more accessible.

eye health

contact lens health week

contact lens health week 2025

contact lens health

contact lens

Contact Lens Health Week, observed annually in the third week of August, comes to a close today. This year, it ran from August 18 to 22, serving as an important reminder of how crucial eye health is in our daily lives. While it may seem like a niche health observance, the initiative highlights an issue that affects millions worldwide: the proper care and safe use of contact lenses.Why Eye Health Cannot Be OverlookedVision is one of the most vital senses, yet it is often taken for granted. With modern technology, access to corrective options such as glasses, contact lenses, surgeries, and even transplants has made many believe that eyesight will always be easily restorable. But experts emphasize that carelessness with something as simple as contact lenses can lead to lasting damage. Contact lenses sit directly on the eye, and poor hygiene or overuse can compromise vision. This is exactly why Contact Lens Health Week remains significant.A Brief History of Vision CorrectionThe journey of improving human sight stretches back centuries. Records suggest that spectacles first appeared in the late 1200s to early 1300s, with Salvino D’Armate often credited as their inventor. Initially, these crude lenses were luxury items reserved for the wealthy. By the time of the industrial revolution, glasses became widely available and affordable, changing lives across classes.In the early 1800s, scientist Thomas Young built the first prototype of a contact lens, using wax and water-filled lenses. Over the following century and a half, various improvements led to a more practical design. By the 1940s, significant strides had been made in creating lenses suitable for everyday wear. However, it wasn’t until the introduction of soft lenses in the 1970s that contact lenses truly became mainstream.The Rise of Contact Lenses, and the RisksToday, millions of people choose between glasses and contact lenses. Contact lenses offer freedom, convenience, and in many cases, improved aesthetics. Yet, their popularity has also led to widespread misuse. Many users overlook the two key rules: sticking to the replacement schedule and respecting the wear schedule. Even the most advanced lenses should not be worn beyond 30 consecutive days and nights. Ignoring this can reduce oxygen flow to the eyes, cause infections, and in severe cases, lead to vision loss.Why Contact Lens Health Week MattersThe week serves as a call to action for everyone who relies on contact lenses. It emphasizes the need for proper cleaning, regular replacement, and awareness of risks linked to negligence. Simple practices, like washing hands before touching lenses, never reusing solution, and removing lenses before sleeping, can prevent long-term harm.Milestones in Contact Lens Development1508: Leonardo da Vinci illustrates the first concept of contact lenses.1939: Plastic technology enables the creation of the first plastic contact lenses.1971: Soft contact lenses gain public approval for comfort.1987: Disposable soft contact lenses are introduced, making them more accessible.

contact lens health week 2025: why is it important for us to observe a week for eye health?

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

A Pill In Your Cabinet That 'Millions' Take Could Help Fight The Deadliest Breast Cancer

Quick Stories

First Human West Nile Case Reported In Maryland While Kansas Battles Six Infections

Young Kids Should Get Covid-19 Vaccine: US Pediatric Group Breaks Away From CDC Guidelines

Contact Lens Health Week 2025: Why Is It Important For Us To Observe A Week For Eye Health?

Health Conditions A-Z

First Human West Nile Case Reported In Maryland While Kansas Battles Six Infections

Serena Williams Opens Up About Losing 31 lbs With GLP-1 Medication; Is This Breaking Stigma Or Joining The Trend?

A Pill In Your Cabinet That 'Millions' Take Could Help Fight The Deadliest Breast Cancer